ARCHIVES

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Study Validates “PEM” Scans As Biopsy Guidance Method

April 29, 2011

Zydelig Tablets Approved For Three Blood Cancers

July 25, 2014

Cancer Letter Skips Next Two Weeks

September 2, 1988

NCI Lists Projected Grant Paylines

February 16, 1996

Stop Cancer Changes Leaders, Focus, Sends $1.6M To NCI

August 30, 1991

New NIH Program To Develop Therapies For Rare, Neglected Diseases

June 19, 2009